NP49426a Transition Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

This public procurement record has 2 releases in its history.

Award

23 Sep 2026 at 10:55

Tender

20 May 2026 at 11:34

Summary of the contracting process

Public Services Delivery Scotland, acting for NHS Scotland, procured pharmaceutical products for NHS Scotland and related health bodies across Scotland. The requirement was divided into medicine groups: RSV immunisations; analgesics, anaesthetics and medicines for musculoskeletal disorders; cardiovascular, respiratory and HIV medicines; psychiatry and neurology medicines; cancer medicines; and gastrointestinal, endocrine, nutrition and blood medicines. The procurement also included a skin medicines lot, although no award or contract for that lot is recorded. The RSV lot was for monoclonal antibody medicines. This is a medicines supply requirement rather than a clinical service or construction contract, covering supply to NHS Scotland bodies and Integrated Joint Boards.

The open-procedure framework procurement is recorded as complete, with contracts active and signed. Awards are recorded for six lots; each is a multi-supplier framework by product line. Signed dates, awarded contract values and periods are: RSV immunisations, 29 July 2026, £4,852,424, 1 August 2026–31 July 2028, awarded to Merck Sharp & Dohme UK and Sanofi; analgesics, anaesthetics and MSD generics, 27 July 2026, £2,267,492, 1 August 2026–30 November 2028, Crescent Pharma and CST Pharma; cardiovascular, respiratory and HIV medicines, 27 July 2026, £4,334,476, 1 August 2026–30 April 2028, Crescent Pharma, Teva, GlaxoSmithKline, Merck Sharp & Dohme, Focus Pharmaceuticals and MSN Labs. Psychiatry and neurology: £8,427,628, signed 18 July 2026, through 30 September 2028; cancer: £2,514,000, signed 27 July 2026, through 31 January 2027; gastrointestinal, endocrine, nutrition and blood: £3,127,716, signed 23 July 2026, through 31 July 2027. These three lots started 1 August 2026. Price accounted for 95% of evaluation and supply chain quality 5%.

The awards show demand for suppliers able to provide medicines across several therapeutic areas through product-line frameworks, with multiple suppliers appointed in most awarded groups. Credible suppliers need a valid, current UK Marketing Authorisation approved by the MHRA for every medicine offered, and BS EN ISO 9001 certification or an equivalent quality standard; subcontractors must also hold the quality certification. Products must meet MHRA good-practice and National Patient Safety Agency requirements for packaging and labelling, and bidders must be able to provide samples on request. The selection requirements also called for a climate change plan describing planned actions to reduce emissions and evidence that the organisation had considered the climate emergency. Competition was strongest in the cancer and psychiatry and neurology groups, with 16 and 14 bids respectively; these results indicate the need to compete on price while demonstrating reliable supply-chain capability.

How relevant is this notice?

Notice Information

Notice Title

NP49426a Transition Medicines

Notice Description

Supply of Transition Medicines to NHS Scotland.

Lot Information

RSV Immunisations

Supply of RSV Monoclonal Antibody Medicines to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Skin Medicines

Supply of skin medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-three (33) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Analgesics, Anaesthetics & MSD Generics

Supply of Analgesics, Anaesthetics & MSD Generics medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-two (32) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Psychiatry and Neurology Medicines

Supply of Psychiatry and Neurology Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-two (22) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cancer Medicines

Supply of Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of forty-one (41) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Gastrointestinal, Endocrine, Nutrition, Blood Medicines

Supply of Gastrointestinal, Endocrine, Nutrition, Blood Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Antimicrobial and Genitourinary Medicines

Supply of Antimicrobial and Genitourinary Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of fifteen (15) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cardiovascular, Respiratory, and HIV Medicines

Supply of Cardiovascular, Respiratory, and HIV Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-one (31) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-069d17
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/090003-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£61,847,781 £10M-£100M
Lots Value
£78,933,168 £10M-£100M
Awards Value
Not specified
Contracts Value
£25,523,736 £10M-£100M

Notice Dates

Publication Date
23 Sep 20261 months ago
Submission Deadline
22 Jun 2026Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
26
Supplier Names

Merck Sharp & Dohme UK Ltd

Aventis Pharma ltd

Crescent Pharma Limited

CST Pharma Limited

Teva UK Limited

GlaxoSmithKline UK Limited

Focus Pharmaceuticals Ltd

MSN Labs

Zentiva

Viatris UK Healthcare Ltd

STADA UK - Thornton & Ross

Celix Pharma Ltd.

Reig Jofre UK limited

Gerot Lannach UK Ltd

Ranbaxy (UK) Ltd

Colonis Pharma Ltd

Orifarm UK

Janssen-Cilag Ltd

Consilient Health Ltd

Pfizer Ltd

Fresenius Kabi Limited

Dr.Reddy's Laboratories (UK) Limited

Martindale Pharma

Brancaster Pharma Ltd

Bowmed Ibisqus Limited

Novumgen Limited

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...